SystImmune and Bristol Myers Squibb announce interim Phase III data showing Iza-bren significantly improves outcomes in previously treated triple-negative breast cancer (TNBC) patients. SystImmune, Inc. and Bristol Myers Squibb have announced positive topline results from a pivotal Phase III clinical…
Evox Therapeutics Ltd collaborates with Rett Syndrome Research Trust to evaluate its ExoEdit® exosome-based gene editing platform as a potential therapeutic approach for Rett syndrome. Evox Therapeutics Ltd has announced the launch of a new strategic collaboration with the Rett…
New findings reinforce the clinical value of Aventa Lymphoma test for detecting diagnostically and therapeutically relevant genomic rearrangements in routine pathology samples. Arima Genomics, Inc., a precision oncology company harnessing whole-genome sequence and structural information to advance cancer therapy selection,…
New clinical study results highlight significant reductions in residual stone volume and follow-up health complications with Calyxo’s CVAC System. Calyxo, Inc., a medical device innovator transforming the treatment of kidney stones, has announced the peer-reviewed publication of pivotal clinical data…
ENDRA Life Sciences Demonstrates High Consistency in TAEUS® Liver Device for MASLD Monitoring ENDRA Life Sciences Inc , a leading innovator in thermoacoustic imaging technology, has reported highly favorable results from a recent clinical study evaluating the measurement consistency and…
Sierra Space Appoints Dan Jablonsky as Chief Executive Officer to Drive Next Phase of Growth Across National Security and Space Markets Sierra Space, a leading aerospace and defense technology company recognized for delivering critical solutions to the nation’s most strategic…
bioAffinity Technologies Initiates Study with Brooke Army Medical Center to Expand Early Lung Cancer Detection Using CyPath® Lung Test bioAffinity Technologies, Inc. a leading biotechnology company dedicated to advancing noninvasive diagnostics and early cancer detection, has announced a groundbreaking study…
Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine Asahi Kasei Pharma, a leading innovator in the pharmaceutical sector, announced a significant strategic advancement in its drug discovery pipeline through an exclusive global license agreement with…